Veterinary Diagnostics Market is Estimated at USD 22.10 Billion for 2034; Rising Pet Ownership and Disease Surveillance Drive Demand for Veterinary Diagnostics

The global veterinary diagnostics market size was valued at USD 8.78 billion in 2025. The market is projected to grow from USD 9.72 billion in 2026 to USD 22.10 billion by 2034, exhibiting a CAGR of 10.82% during the forecast period. Fortune Business Insights™ presents this information in its report titled, “Veterinary Diagnostics Market Size, Share & Industry Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Hematology, Immunodiagnostics, Molecular Diagnostics, Diagnostic Imaging, Clinical Biochemistry, and Others), By Animal Type (Livestock {Bovine, Porcine, and Others}, and Companion {Feline, Canine, and Others}), By End User (Veterinary Hospitals & Clinics, Veterinary Reference Laboratories, and Others), and Regional Forecast, 2026-2034”.

Veterinary diagnostics covers a range of testing solutions used to identify diseases, assess animal health, and monitor treatment outcomes across livestock and companion animals. The market is experiencing growth as pet ownership increases, livestock disease monitoring becomes more important, and concerns over diseases affecting both animals and humans continue to rise. In addition, the growing use of point-of-care and molecular testing is enabling faster and more advanced diagnostic practices. These developments are expected to support the expansion of the market.

Acquisition Expands Zoetis’ Cloud-Based Veterinary Diagnostic Capabilities

In July 2026, Zoetis agreed to acquire VitalRADS, strengthening the relationship established through their partnership in August 2025. The acquisition will enhance Zoetis’ Virtual Reference Lab offering with cloud-based teleradiology and advanced imaging workflow technology. It will also provide veterinary professionals with 24/7 access to veterinary specialists.

Frequent Disease Outbreaks Drive Greater Demand for Animal Testing

The rising incidence of avian influenza, African swine fever, and other cross-border animal diseases is encouraging governments and livestock producers to strengthen disease monitoring and veterinary diagnostics programs. Early detection helps limit disease transmission, animal losses, and trade restrictions, further increasing the need for PCR assays, ELISA kits, laboratory testing services, and rapid tests. In addition, mandatory screening and outbreak-response programs are increasing testing volumes across borders, farms, and veterinary reference laboratories, supporting overall market growth.

However, high veterinary diagnostic costs can limit testing uptake, particularly among uninsured pets and price-sensitive owners, thereby restraining the adoption of advanced diagnostic solutions and veterinary diagnostics market growth.

Key Players Expand Product Portfolio and Adopt Advanced Solutions to Strengthen Market Position

The competitive landscape of the veterinary diagnostics market is consolidated, with leading companies maintaining notable market shares through product development, strategic initiatives, and innovative solutions. Companies are expanding their diagnostic capabilities, including point-of-care workflows, multiplex testing, and integrated laboratory-clinic connectivity, to improve competitiveness. Strategic acquisitions are also helping players expand their veterinary diagnostic laboratory presence across key regions.

List of Key Companies Profiled in the Report

• IDEXX (U.S.)
• Zoetis Services LLC (U.S.)
• Antech Diagnostics, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Virbac (France)
• BIOMÉRIEUX (France)
• Neogen Corporation (U.S.)
• Shenzhen Mindray Animal Medical Technology Co., LTD. (China)
• Randox Laboratories Ltd. (U.K.)
• INDICAL BIOSCIENCE GmbH (Germany)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/veterinary-diagnostics-market-101040

Notable Industry Development

• January 2026: IDEXX introduced the ImageVue DR50 Plus Digital Imaging System for veterinary practices, featuring AI-supported image optimization and connected imaging workflows. The system also offers radiation exposure that is up to 25% lower than the earlier DR50 system, improving its imaging capabilities for veterinary use.

Further Report Findings

• Based on regional analysis, North America dominated the veterinary diagnostics market share in 2024 and in 2025. The continued growth in the region is supported by a growing population of companion-animals and increased expenditure on advanced as well as preventive pet care.
• Europe, on the other hand, is expected to register a CAGR of 11.06% over the forecast period. This growth is driven by advanced veterinary infrastructures across the region, with facilities including chronic-disease monitoring, diagnostic imaging, senior-pet testing, and wellness screening.
• Moreover, Asia Pacific is projected to become the fastest-growing region in the global market. Its growth is due to large volumes of swine, cattle, poultry, and aquaculture availability, increasing demand for herd-health diagnostics as well as infectious-disease screening.
• On the basis of product type, the reagents & consumables segment held the dominant share of the market in 2025. The segment’s leadership is due to frequent use of consumables such as assay kits, slides, cartridges, controls, calibrators, and sample-preparation products with each veterinary screening.
• By end user, the veterinary reference laboratories segment led in 2025 as they manage large numbers of samples using centralized automated systems, molecular testing, pathology, immunodiagnostics, and expert interpretation.

Table of Segmentation